{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:21:48Z","timestamp":1794748908607,"version":"4.9.1"},"reference-count":172,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>\n                    Brucellosis is a bacterial zoonosis caused by\n                    <jats:italic>Brucella<\/jats:italic>\n                    spp. which can lead to heavy economic losses and severe human diseases. Thus, controlling brucellosis is very important. Due to humans easily gaining brucellosis from animals, animal brucellosis control programs can help the eradication of human brucellosis. There are two popular vaccines against animal brucellosis. Live attenuated\n                    <jats:italic>Brucella abortus<\/jats:italic>\n                    strain 19 (S19 vaccine) is the first effective and most extensively used vaccine for the prevention of brucellosis in cattle. Live attenuated\n                    <jats:italic>Brucella melitensis<\/jats:italic>\n                    strain Rev.1 (Rev.1 vaccine) is the most effective vaccine against caprine and ovine brucellosis. Although these two vaccines provide good immunity for animals against brucellosis, the expense of persistent serological responses is one of the main problems of both vaccines. The advantages and limitations of\n                    <jats:italic>Brucella<\/jats:italic>\n                    vaccines, especially new vaccine candidates, have been less studied. In addition, there is an urgent need for new strategies to control and eradicate this disease. Therefore, this narrative review aims to present an updated overview of the available different types of brucellosis vaccines.\n                  <\/jats:p>","DOI":"10.3389\/fvets.2022.925773","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T01:41:21Z","timestamp":1658108481000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":93,"title":["Evaluation of Brucellosis Vaccines: A Comprehensive Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Mohsen","family":"Heidary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Dashtbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roya","family":"Ghanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzie","family":"Mahdizade Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjess","family":"Bostanghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atieh","family":"Darbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Navidifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malihe","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,18]]},"reference":[{"key":"B1","volume-title":"Brucellosis in Humans and Animals","author":"Corbel","year":"2006"},{"key":"B2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S1369-5274(00)00165-X","article-title":"Brucellosis: a worldwide zoonosis","volume":"4","author":"Boschiroli","year":"2001","journal-title":"Curr Opin Microbiol."},{"key":"B3","first-page":"85","article-title":"The use of live vaccine for vaccination of human beings against brucellosis in the USSR","volume":"24","author":"Vershilova","year":"1961","journal-title":"Bull World Health Organ."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.ijantimicag.2010.06.013","article-title":"The changing Brucella ecology: novel reservoirs, new threats","volume":"36","author":"Pappas","year":"2010","journal-title":"Int J Antimicrob Agents."},{"key":"B5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1017\/S0031182005007699","article-title":"OIE manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees) 5th edn. Volumes 1 & 2. World Organization for Animal Health 2004. ISBN 92 9044 622 6.80 140","volume":"130","author":"Stear","year":"2005","journal-title":"Parasitology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/iai.53.2.245-251.1986","article-title":"Comparison of living and nonliving vaccines for Brucella abortus in BALB\/c mice","volume":"53","author":"Montaraz","year":"1986","journal-title":"Infect Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.18869\/modares.iem.2.4.32","article-title":"Vaccines and vaccine candidates against brucellosis","volume":"2","author":"Mansoori","year":"2016","journal-title":"Infect Epidemiol Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.molimm.2015.04.004","article-title":"A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy","volume":"66","author":"Li","year":"2015","journal-title":"Mol Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.micpath.2016.04.009","article-title":"Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB\/c mice","volume":"95","author":"Truong","year":"2016","journal-title":"Microbial Pathogenesis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-017-0422-9","article-title":"Characterization of Brucella abortus mutant strain \u039422915, a potential vaccine candidate","volume":"48","author":"Bao","year":"2017","journal-title":"Vet Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1099\/mic.0.000170","article-title":"Booster vaccination with safe, modified, live-attenuated mutants of Brucella abortus strain RB51 vaccine confers protective immunity against virulent strains of B. abortus and Brucella canis in BALB\/c mice","volume":"161","author":"Truong","year":"2015","journal-title":"Microbiology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1389201014666131226123016","article-title":"Research progress in live attenuated Brucella vaccine development","volume":"14","author":"Wang","year":"2013","journal-title":"Curr Pharm Biotechnol."},{"key":"B15","first-page":"233","article-title":"Brucella melitensis strain Rev I as a vaccine for cattle","volume":"42","author":"Horwell","year":"1971","journal-title":"J S Afr Vet Assoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.vaccine.2015.09.116","article-title":"Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections","volume":"34","author":"Zhu","year":"2016","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0264-410X(95)93135-V","article-title":"Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes","volume":"13","author":"Verger","year":"1995","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e01079","DOI":"10.1016\/j.heliyon.2018.e01079","article-title":"Development of new generation of vaccines for Brucella abortus","volume":"4","author":"Gheibi","year":"2018","journal-title":"Heliyon"},{"key":"B19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.vaccine.2015.11.030","volume":"34","author":"Truong","year":"2016","journal-title":"Brucella abortus"},{"key":"B20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/1348-0421.12065","article-title":"Brucella melitensis 16 M \u0394hfq attenuation confers protection against wild-type challenge in BALB\/c mice","volume":"57","author":"Zhang","year":"2013","journal-title":"Microbiol Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.micpath.2017.09.016","article-title":"The Brucella melitensis M5-90\u0394manB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB\/c mice","volume":"112","author":"Zhang","year":"2017","journal-title":"Microb Pathog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.4014\/jmb.1908.08056","article-title":"Brucella melitensis omp31 mutant is attenuated and confers protection against virulent Brucella melitensis challenge in BALB\/c mice","volume":"30","author":"Verdiguel-Fern\u00e1ndez","year":"2020","journal-title":"J Microbiol Biotechnol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.micpath.2018.08.052","article-title":"Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant","volume":"124","author":"Li","year":"2018","journal-title":"Microb Pathog."},{"key":"B24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1128\/mSphere.00172-20","article-title":"Evaluation of the efficacy of the Brucella canis RM6\/66 \u0394vjbR vaccine candidate for protection against B. canis infection in mice","volume":"5","author":"Stranahan","year":"2020","journal-title":"Msphere"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/IAI.05330-11","article-title":"Protective efficacy and safety of Brucella melitensis 16M\u0394mucR against intraperitoneal and aerosol challenge in BALB\/c mice","volume":"79","author":"Arenas-Gamboa","year":"2011","journal-title":"Infect Immun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1128\/IAI.05080-11","article-title":"Protective live oral brucellosis vaccines stimulate Th1 and Th17 cell responses","volume":"79","author":"Clapp","year":"2011","journal-title":"Infect Immun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11274-016-2015-6","article-title":"The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB\/c mice","volume":"32","author":"Zhang","year":"2016","journal-title":"World J Microbiol Biotechnol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.3892\/etm.2015.2619","article-title":"Brucella melitensis 16M\u0394TcfSR as a potential live vaccine allows for the differentiation between natural and vaccinated infection","volume":"10","author":"Li","year":"2015","journal-title":"Exp Ther Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.micinf.2014.06.013","article-title":"Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate","volume":"16","author":"Wang","year":"2014","journal-title":"Microbes Infection."},{"key":"B30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.micpath.2017.03.045","article-title":"Rough Brucella strain RM57 is attenuated and confers protection against Brucella melitensis","volume":"107","author":"Feng","year":"2017","journal-title":"Microb Pathog"},{"key":"B31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/1348-0421.12850","article-title":"The candidate vaccine strain Brucella ovis \u0394 abcBA is protective against Brucella melitensis infection in mice","volume":"64","author":"Costa","year":"2020","journal-title":"Microbiol Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0136865","DOI":"10.1371\/journal.pone.0136865","article-title":"Encapsulated Brucella ovis lacking a putative ATP-binding cassette transporter (\u0394 abcBA) protects against wild type Brucella ovis in rams","volume":"10","author":"Silva","year":"2015","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1297-9716-45-61","article-title":"Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection","volume":"45","author":"Sancho","year":"2014","journal-title":"Vet Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.vaccine.2018.12.070","article-title":"Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH","volume":"37","author":"Smith","year":"2019","journal-title":"Vaccine."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.vaccine.2016.02.025","article-title":"Delta-pgm, a new live-attenuated vaccine against Brucella suis","volume":"34","author":"Czibener","year":"2016","journal-title":"Vaccine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"108447","DOI":"10.1016\/j.vetmic.2019.108447","article-title":"Rough Brucella neotomae provides protection against Brucella suis challenge in mice","volume":"239","author":"Jain-Gupta","year":"2019","journal-title":"Vet Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12275-014-3689-9","article-title":"A potent Brucella abortus 2308 \u0394ery live vaccine allows for the differentiation between natural and vaccinated infection","volume":"52","author":"Zhang","year":"2014","journal-title":"J Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1128\/CVI.00164-14","article-title":"Characterization and protective property of Brucella abortus cydC and looP mutants","volume":"21","author":"Truong","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3389\/fmicb.2015.01570","article-title":"Deletion of the small RNA chaperone protein Hfq down regulates genes related to virulence and confers protection against wild-type Brucella challenge in mice","volume":"6","author":"Lei","year":"2016","journal-title":"Front Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1016\/j.vaccine.2016.09.004","article-title":"Vaccination with a \u0394norD \u0394znuA Brucella abortus mutant confers potent protection against virulent challenge","volume":"34","author":"Yang","year":"2016","journal-title":"Vaccine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.micpath.2017.01.043","article-title":"Brucella abortus 2308\u0394NodV\u0394NodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB\/c mice","volume":"106","author":"Li","year":"2017","journal-title":"Microb Pathog."},{"key":"B42","doi-asserted-by":"publisher","first-page":"103865","DOI":"10.1016\/j.micpath.2019.103865","article-title":"Deletion of the LuxR-type regulator VjbR in Brucella canis affects expression of type IV secretion system and bacterial virulence, and the mutant strain confers protection against Brucella canis challenge in mice","volume":"139","author":"Liu","year":"2020","journal-title":"Microb Pathog."},{"key":"B43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.molimm.2017.10.011","article-title":"Deletion of the transcriptional regulator GntR down regulated the expression of genes related to virulence and conferred protection against wild-type Brucella challenge in BALB\/c mice","volume":"92","author":"Li","year":"2017","journal-title":"Mol Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-015-0199-7","article-title":"Recent advances in Brucella abortus vaccines","volume":"46","author":"Dorneles","year":"2015","journal-title":"Vet Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biologicals.2012.01.002","article-title":"Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB\/c mice","volume":"40","author":"Al-Mariri","year":"2012","journal-title":"Biologicals."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-021-00801-y","article-title":"A new candidate vaccine for human brucellosis based on influenza viral vectors: a preliminary investigation for the development of an immunization schedule in a guinea pig model","volume":"10","author":"Bugybayeva","year":"2021","journal-title":"Infect Dis Poverty."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1080\/14760584.2016.1208089","article-title":"Influenza viral vector based Brucella abortus vaccine: a novel vaccine candidate for veterinary practice","volume":"15","author":"Tabynov","year":"2016","journal-title":"Expert Rev Vaccines."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1128\/IAI.70.4.1915-1923.2002","article-title":"Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen","volume":"70","author":"Al-Mariri","year":"2002","journal-title":"Infect Immun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fvets.2020.00058","article-title":"Evaluation of duration of immunogenicity and protective efficacy of improved influenza viral vector\u2013based Brucella abortus vaccine against Brucella melitensis infection in sheep and goats","volume":"7","author":"Mailybayeva","year":"2020","journal-title":"Front Vet Sci"},{"key":"B51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.vetimm.2019.02.001","article-title":"Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model","volume":"209","author":"Senevirathne","year":"2019","journal-title":"Vet Immunol Immunopathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1438929","DOI":"10.1155\/2020\/1438928","article-title":"Development of human vectored brucellosis vaccine formulation: assessment of safety and protectiveness of influenza viral vectors expressing Brucella immunodominant proteins in mice and guinea pigs","volume":"2020","author":"Bugybayeva","year":"2020","journal-title":"BioMed Res Int"},{"key":"B53","doi-asserted-by":"publisher","first-page":"101470","DOI":"10.1016\/j.cimid.2020.101470","article-title":"High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species","volume":"70","author":"Mohammadi","year":"2020","journal-title":"Comp Immunol Microbiol Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1139\/cjm-2019-0261","article-title":"Production of Brucella melitensis Omp16 protein fused to the human interleukin 2 in Lactococcus lactis MG1363 toward developing a Lactococcus-based vaccine against brucellosis","volume":"66","author":"Rezaei","year":"2020","journal-title":"Can J Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.9775\/kvfd.2017.18644","article-title":"Immunogenicity of recombinant adenovirus co-expressing the L7\/L12 and BCSP31 proteins of Brucella abortus","volume":"24","author":"Guo-Zhen","year":"2018","journal-title":"Kafkas \u00dcniversitesi Veteriner Fak\u00fcltesi Dergisi"},{"key":"B56","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/hum.2014.007","article-title":"Challenges in manufacturing adenoviral vectors for global vaccine product deployment","volume":"25","author":"Vellinga","year":"2014","journal-title":"Hum Gene Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.4142\/jvs.2021.22.e15","article-title":"Protective efficacy of attenuated Salmonella Typhimurium strain expressing BLS, Omp19, PrpA, or SOD of Brucella abortus in goats","volume":"22","author":"Leya","year":"2021","journal-title":"J Vet Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-020-0735-y","article-title":"Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7\/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge","volume":"51","author":"Senevirathne","year":"2020","journal-title":"Vet Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"103857","DOI":"10.1016\/j.micpath.2019.103857","article-title":"Enhancement of host infectivity, immunity, and protective efficacy by addition of sodium bicarbonate antacid to oral vaccine formulation of live attenuated Salmonella secreting Brucella antigens","volume":"138","author":"Hewawaduge","year":"2020","journal-title":"Microb Pathog."},{"key":"B60","doi-asserted-by":"publisher","first-page":"ftx094","DOI":"10.1093\/femspd\/ftx094","article-title":"Protective efficacy by various doses of a new brucellosis vaccine candidate based on Salmonella strains expressing Brucella abortus BSCP31, Omp3b and superoxide dismutase against brucellosis in murine model","volume":"75","author":"Kim","year":"2017","journal-title":"Pathogens Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-11-69","article-title":"Influenza viral vectors expressing the Brucella OMP16 or L7\/L12 proteins as vaccines against B. abortus infection","volume":"11","author":"Tabynov","year":"2014","journal-title":"Virol J."},{"key":"B62","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.rvsc.2015.03.030","article-title":"Immunogenic response to a recombinant pseudorabies virus carrying bp26 gene of Brucella melitensis in mice","volume":"100","author":"Yao","year":"2015","journal-title":"Res Vet Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.vaccine.2011.12.088","article-title":"Oral immunization of mice with recombinant Lactococcus lactis expressing Cu, Zn superoxide dismutase of Brucella abortus triggers protective immunity","volume":"30","author":"S\u00e1ez","year":"2012","journal-title":"Vaccine."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e00048","DOI":"10.1128\/MMBR.00048-20","article-title":"The role of neutrophils in brucellosis","volume":"84","author":"Moreno","year":"2020","journal-title":"Microbiol Mol Biol Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"D40","DOI":"10.1016\/j.vaccine.2009.08.058","article-title":"Brucellosis: the case for live, attenuated vaccines","volume":"27","author":"Ficht","year":"2009","journal-title":"Vaccine."},{"key":"B66","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1016\/j.vaccine.2011.04.088","article-title":"Co-immunization with interlukin-18 enhances the protective efficacy of liposomes encapsulated recombinant Cu\u2013Zn superoxide dismutase protein against Brucella abortus","volume":"29","author":"Singha","year":"2011","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4014\/jmb.1505.05028","article-title":"Immunization of mice with recombinant Brucella abortus organic hydroperoxide resistance (Ohr) protein protects against a virulent Brucella abortus 544 Infection","volume":"26","author":"Hop","year":"2016","journal-title":"J Microbiol Biotechnol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1128\/IAI.00123-09","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1016\/j.vaccine.2014.09.013","article-title":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection","volume":"32","author":"Ghasemi","year":"2014","journal-title":"Vaccine."},{"key":"B70","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fvets.2020.00576","article-title":"Comparison of immune effects between Brucella recombinant Omp10-Omp28-L7\/L12 proteins expressed in eukaryotic and prokaryotic systems","volume":"7","author":"Zhu","year":"2020","journal-title":"Front Vet Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"ftaa002","DOI":"10.1093\/femspd\/ftaa002","article-title":"A combined subunit vaccine comprising BP26, Omp25 and L7\/L12 against brucellosis","volume":"77","author":"Gupta","year":"2019","journal-title":"Pathogens Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.molimm.2018.10.002","article-title":"Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7\/L12+ rTOmp31+ rSOmp2b) in two different adjuvant formulations in BALB\/c mice","volume":"103","author":"Golshani","year":"2018","journal-title":"Mol Immunol."},{"key":"B73","first-page":"11","article-title":"A recombinant chimera protein as a novel Brucella subunit vaccine: protective efficacy and induced immune response in BALB\/c mice","author":"Abdollahi","year":"2018","journal-title":"Jundishapur J Microbiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.imlet.2017.10.013","article-title":"Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-\u03b3 and IL-12p70 protective immune response in BALB\/c mice against virulent Brucella","volume":"192","author":"Tadepalli","year":"2017","journal-title":"Immunol Lett"},{"key":"B75","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molimm.2016.01.001","article-title":"Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+ rP39) against B. abortus 544 and B. melitensis 16M infection in murine model","volume":"71","author":"Tadepalli","year":"2016","journal-title":"Mol Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3389\/fmicb.2015.01193","article-title":"Immunization with individual proteins of the Lrp\/AsnC family induces protection against Brucella melitensis 16M challenges in mice","volume":"6","author":"Wang","year":"2015","journal-title":"Front Microbiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2016.04.016","article-title":"A novel recombinant multi-epitope protein against Brucella melitensis infection","volume":"175","author":"Yin","year":"2016","journal-title":"Immunol Lett."},{"key":"B78","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.molimm.2011.08.009","article-title":"Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine","volume":"49","author":"Yang","year":"2011","journal-title":"Mol Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1007\/s11274-012-1056-8","article-title":"Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB\/c mice","volume":"28","author":"Verma","year":"2012","journal-title":"World J Microbiol Biotechnol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s11274-012-1247-3","article-title":"Immunological responses to recombinant cysteine synthase A of Brucella abortus in BALB\/c mice","volume":"29","author":"Jain","year":"2013","journal-title":"World J Microbiol Biotechnol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice","volume":"62","author":"Ghasemi","year":"2014","journal-title":"Mol Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.micpath.2017.12.045","article-title":"Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen","volume":"115","author":"Yousefi","year":"2018","journal-title":"Microb Pathog."},{"key":"B83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molimm.2018.04.002","article-title":"Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model","volume":"99","author":"Paul","year":"2018","journal-title":"Mol Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.vaccine.2018.04.019","article-title":"Immunization of BALB\/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus","volume":"36","author":"Hop","year":"2018","journal-title":"Vaccine"},{"key":"B85","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1007\/s00253-018-9314-9","article-title":"Protective and therapeutic efficacy study of divalent fusion protein rL7\/L12-Omp25 against B. abortus 544 in presence of IFN\u03b3","volume":"102","author":"Paul","year":"2018","journal-title":"Appl Microbiol Biotechnol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.vetmic.2018.11.022","article-title":"Intranasally administered anti-Brucella subunit vaccine formulation induces protective immune responses against nasal Brucella challenge","volume":"228","author":"Senevirathne","year":"2019","journal-title":"Vet Microbiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"105829","DOI":"10.1016\/j.intimp.2019.105829","article-title":"Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I: C against Brucella melitensis and Brucella abortus infection","volume":"75","author":"Sadeghi","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"106573","DOI":"10.1016\/j.intimp.2020.106573","article-title":"Evaluation of Poly (I: C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice","volume":"84","author":"Golshani","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12917-019-2074-7","article-title":"In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB\/c mice","volume":"15","author":"Nazifi","year":"2019","journal-title":"BMC Vet Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e00084","DOI":"10.1128\/CMR.00084-18","article-title":"Factors that influence the immune response to vaccination","volume":"32","author":"Zimmermann","year":"2019","journal-title":"Clin Microbiol Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11274-017-2405-4","article-title":"Brucella abortus phosphoglyceromutase and dihydrodipicolinate reductase induce Th1 and Th2-related immune responses","volume":"34","author":"Li","year":"2018","journal-title":"World J Microbiol Biotechnol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/15321819.2015.1132231","article-title":"Characterization and immunogenicity of outer membrane vesicles from Brucella abortus","volume":"37","author":"Kaur","year":"2016","journal-title":"J Immunoassay Immunochem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.vetmic.2016.10.027","article-title":"Comparison of potential protection conferred by three immunization strategies (protein\/protein, DNA\/DNA, and DNA\/protein) against Brucella infection using Omp2b in BALB\/c Mice","volume":"197","author":"Golshani","year":"2016","journal-title":"Vet Microbiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1166\/mex.2020.1645","article-title":"Evaluation of a recombinant bacillus calmette-gu\u00e9rin vaccine expressing P39-L7\/L12 of Brucella melitensis: an immunization strategy against brucellosis in BALB\/c mice","volume":"10","author":"Zhou","year":"2020","journal-title":"Materials Express."},{"key":"B97","first-page":"1","article-title":"Evaluation of immunogenicity and protective efficacy of a liposome containing Brucella abortus S19 outer membrane protein in BALB\/c mice","volume":"17","author":"Mukherjee","year":"2016","journal-title":"Iran J Vet Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1128\/CVI.00527-14","article-title":"Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB\/c mice","volume":"21","author":"Clausse","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4014\/jmb.1509.09061","article-title":"Immune modulation of recombinant OmpA against Brucella abortus 544 infection in mice","volume":"26","author":"Simborio","year":"2016","journal-title":"J Microbiol Biotechnol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"e29552","DOI":"10.1371\/journal.pone.0029552","article-title":"Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection","volume":"7","author":"Fu","year":"2012","journal-title":"PLoS ONE."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3389\/fvets.2020.577026","article-title":"Immunization with a combination of four recombinant Brucella abortus Proteins Omp16, Omp19, Omp28, and L7\/L12 induces T helper 1 immune response against virulent B. abortus 544 infection in BALB\/c mice","volume":"7","author":"Huy","year":"2021","journal-title":"Front Vet Sci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s12010-016-2076-x","article-title":"Immunogenicity analysis of a novel subunit vaccine candidate molecule\u2014recombinant L7\/L12 ribosomal protein of Brucella suis","volume":"179","author":"Du","year":"2016","journal-title":"Appl Biochem Biotechnol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsle\/fnv003","article-title":"Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB\/c mice","volume":"362","author":"Hop","year":"2015","journal-title":"FEMS Microbiol Lett."},{"key":"B104","doi-asserted-by":"publisher","first-page":"104137","DOI":"10.1016\/j.micpath.2020.104137","article-title":"Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB\/c mice","volume":"143","author":"Huy","year":"2020","journal-title":"Microbial Pathogen."},{"key":"B105","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molimm.2012.02.126","article-title":"Intradermal immunization with outer membrane protein 25 protects Balb\/c mice from virulent B. abortus 544","volume":"51","author":"Goel","year":"2012","journal-title":"Mol Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.vetimm.2019.02.005","article-title":"Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams","volume":"209","author":"D\u00edaz","year":"2019","journal-title":"Vet Immunol Immunopathol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"107148","DOI":"10.1016\/j.intimp.2020.107148","article-title":"Non-infectious outer membrane vesicles derived from Brucella abortus S19\u0394per as an alternative acellular vaccine protects mice against virulent challenge","volume":"90","author":"Solanki","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.1007\/s00253-015-6787-7","article-title":"Prediction of T cell epitopes of Brucella abortus and evaluation of their protective role in mice","volume":"99","author":"Afley","year":"2015","journal-title":"Appl Microbiol Biotechnol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4142\/jvs.2012.13.3.287","article-title":"Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice","volume":"13","author":"Lim","year":"2012","journal-title":"J Vet Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1016\/j.vaccine.2015.04.030","article-title":"Recombinant L7\/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB\/c mice against the virulent B. abortus 544 infection","volume":"33","author":"Singh","year":"2015","journal-title":"Vaccine."},{"key":"B111","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1016\/j.vaccine.2014.07.106","article-title":"Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis","volume":"32","author":"Singh","year":"2014","journal-title":"Vaccine."},{"key":"B112","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/apm.12400","article-title":"Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections","volume":"123","author":"Abkar","year":"2015","journal-title":"Apmis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4014\/jmb.1811.10066","article-title":"Substantial protective immunity conferred by a combination of Brucella abortus recombinant proteins against Brucella abortus 544 infection in BALB\/c mice","volume":"29","author":"Arayan","year":"2019","journal-title":"J Microbiol Biotechnol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-40084-w","article-title":"The immunogenicity of OMP31 peptides and its protection against Brucella melitensis infection in mice","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci Rep."},{"key":"B115","doi-asserted-by":"publisher","first-page":"6129","DOI":"10.1016\/j.vaccine.2013.07.041","article-title":"The vaccine candidate BLSOmp31 protects mice against Brucella canis infection","volume":"31","author":"Clausse","year":"2013","journal-title":"Vaccine."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1128\/CVI.00447-14","article-title":"Thermostable cross-protective subunit vaccine against Brucella species","volume":"21","author":"Cherwonogrodzky","year":"2014","journal-title":"Clin Vaccine Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.vetmic.2012.07.016","article-title":"Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB\/c mice","volume":"161","author":"Li","year":"2012","journal-title":"Vet Microbiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.molimm.2015.01.009","article-title":"Vaccination with recombinant L7\/L12-truncated Omp31 protein induces protection against Brucella infection in BALB\/c mice","volume":"65","author":"Golshani","year":"2015","journal-title":"Mol Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.3892\/mmr.2018.9735","article-title":"Evaluation of a DNA vaccine encoding Brucella BvrR in BALB\/c mice","volume":"19","author":"Chen","year":"2019","journal-title":"Mol Med Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.micpath.2018.10.016","article-title":"Evaluation of DNA vaccine encoding BCSP31 surface protein of Brucella abortus for protective immunity","volume":"125","author":"Imtiaz","year":"2018","journal-title":"Microb Pathog."},{"key":"B121","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1016\/j.vaccine.2013.06.013","article-title":"Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB\/c mice","volume":"31","author":"Riquelme-Neira","year":"2013","journal-title":"Vaccine."},{"key":"B122","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1016\/j.vaccine.2014.06.012","article-title":"Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB\/c mice","volume":"32","author":"Jain","year":"2014","journal-title":"Vaccine."},{"key":"B123","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.micpath.2017.09.010","article-title":"Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB\/c mice","volume":"111","author":"Li","year":"2017","journal-title":"Microb Pathog."},{"key":"B124","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fcimb.2016.00117","article-title":"Immunogenicity and protective response induced by recombinant plasmids based on the BAB1_0267 and BAB1_0270 open reading frames of Brucella abortus 2308 in BALB\/c mice","volume":"6","author":"G\u00f3mez","year":"2016","journal-title":"Front Cell Infect Microbiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"957","DOI":"10.22038\/IJBMS.2018.27540.6722","article-title":"Immunogenicity evaluation of plasmids encoding Brucella melitensis Omp25 and Omp31 antigens in BALB\/c mice","volume":"21","author":"Shojaei","year":"2018","journal-title":"Iran J Basic Med Sci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fimmu.2017.00125","article-title":"Immunogenicity of a multi-epitope dna vaccine encoding epitopes from Cu\u2013Zn superoxide dismutase and open reading Frames of Brucella abortus in mice","volume":"8","author":"Escalona","year":"2017","journal-title":"Front Immunol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.1016\/j.vaccine.2012.09.039","article-title":"Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB\/c mice","volume":"30","author":"Sislema-Egas","year":"2012","journal-title":"Vaccine."},{"key":"B128","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jconrel.2012.07.030","article-title":"Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles","volume":"162","author":"Da Costa Martins","year":"2012","journal-title":"J Control Release."},{"key":"B129","doi-asserted-by":"publisher","first-page":"151362","DOI":"10.1016\/j.ijmm.2019.151362","article-title":"Elicitation of Th1\/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19","volume":"310","author":"Shim","year":"2020","journal-title":"Int J Medical Microbiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7774\/cevr.2021.10.1.35","article-title":"Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate","volume":"10","author":"Karevan","year":"2021","journal-title":"Clin Exp Vaccine Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"110021","DOI":"10.1016\/j.eurpolymj.2020.110021","article-title":"Immunological effects of two new nanovaccines against Brucella based on OPS and LPS antigens conjugated with PLGA nanoparticles","volume":"139","author":"Afshari","year":"2020","journal-title":"Eur Polym J."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.vaccine.2019.02.005","article-title":"Induction of Th2-related immune responses and production of systemic IgA in mice intranasally immunized with Brucella abortus malate dehydrogenase loaded chitosan nanoparticles","volume":"37","author":"Soh","year":"2019","journal-title":"Vaccine."},{"key":"B133","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.2147\/IJN.S149774","article-title":"Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection","volume":"12","author":"Abkar","year":"2017","journal-title":"Int J Nanomed."},{"key":"B134","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jbiotec.2020.01.016","article-title":"Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection","volume":"310","author":"Sadeghi","year":"2020","journal-title":"J Biotechnol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.2147\/IJN.S249942","article-title":"Nanoparticle-based vaccines for brucellosis: calcium phosphate nanoparticles-adsorbed antigens induce cross protective response in mice","volume":"15","author":"Sadeghi","year":"2020","journal-title":"Int J Nanomed."},{"key":"B136","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.imlet.2018.03.004","article-title":"Intraperitoneal immunization with Urease loaded N-trimethyl Chitosan nanoparticles elicits high protection against Brucella melitensis and Brucella abortus infections","volume":"199","author":"Abkar","year":"2018","journal-title":"Immunol Lett."},{"key":"B137","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.molimm.2015.09.011","article-title":"PLGA (85: 15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: a promising alternate to traditional adjuvants","volume":"68","author":"Singh","year":"2015","journal-title":"Mol Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1080\/21691401.2019.1687490","article-title":"Preparation of a nanovaccine against Brucella melitensis M16 based on PLGA nanoparticles and oligopolysaccharide antigen","volume":"47","author":"Maleki","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/dna.2008.0790","article-title":"A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle","volume":"28","author":"Hu","year":"2009","journal-title":"DNA Cell Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.imbio.2005.09.004","article-title":"Evaluation of Brucella abortus DNA vaccine by expression of Cu\u2013Zn superoxide dismutase antigen fused to IL-2","volume":"211","author":"Gonz\u00e1lez-Smith","year":"2006","journal-title":"Immunobiology."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1128\/IAI.70.5.2507-2511.2002","article-title":"A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB\/c mice","volume":"70","author":"Velikovsky","year":"2002","journal-title":"Infect Immun."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.4314\/tjpr.v15i10.4","article-title":"Induction of protective immune responses in mice by double DNA vaccine encoding of Brucella melitensis Omp31 and Escherichia coli Eae genes","volume":"15","author":"Ranjbar","year":"2016","journal-title":"Trop J Pharmaceut Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3855\/jidc.2296","article-title":"Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis","volume":"7","author":"Al-Mariri","year":"2013","journal-title":"J Infect Develop Countr"},{"key":"B144","doi-asserted-by":"publisher","first-page":"633","DOI":"10.4049\/jimmunol.175.2.633","article-title":"DNA vaccines: progress and challenges","volume":"175","author":"Donnelly","year":"2005","journal-title":"J Immunol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immunity."},{"key":"B146","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1128\/IAI.71.9.4857-4861.2003","article-title":"A DNA vaccine encoding Cu, Zn superoxide dismutase of Brucella abortus induces protective immunity in BALB\/c mice","volume":"71","author":"Onate","year":"2003","journal-title":"Infect Immun."},{"key":"B147","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect Immun."},{"key":"B148","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/dna.2006.0552","article-title":"A combined DNA vaccine encoding BCSP31, SOD, and L7\/L12 confers high protection against Brucella abortus 2308 by inducing specific CTL responses","volume":"26","author":"Yu","year":"2007","journal-title":"DNA Cell Biol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4161\/hv.18389","article-title":"Immunogenicity of a multi-epitope DNA vaccine against hantavirus","volume":"8","author":"Zhao","year":"2012","journal-title":"Hum Vaccin Immunother."},{"key":"B150","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cyto.2004.12.009","article-title":"Interferon-\u03b3 associated cytokines and chemokines produced by spleen cells from Brucella-immune mice","volume":"30","author":"Paranavitana","year":"2005","journal-title":"Cytokine."},{"key":"B151","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clin Vaccine Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1128\/IAI.68.6.3290-3296.2000","article-title":"Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses","volume":"68","author":"Vemulapalli","year":"2000","journal-title":"Infect Immun."},{"key":"B153","doi-asserted-by":"publisher","first-page":"18336","DOI":"10.1073\/pnas.1110566108","article-title":"Regulatory T cells inhibit acute IFN-\u03b3 synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10","volume":"108","author":"Sojka","year":"2011","journal-title":"Proc Nat Acad Sci USA."},{"key":"B154","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.immuni.2004.11.016","article-title":"Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages\/neutrophils: protective and deleterious effects","volume":"22","author":"Grivennikov","year":"2005","journal-title":"Immunity."},{"key":"B155","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.14309\/ctg.0000000000000127","article-title":"Risk for colorectal neoplasia in patients with Helicobacter pylori infection: a systematic review and meta-analysis","volume":"11","author":"Choi","year":"2020","journal-title":"Clin Transl Gastroenterol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1099\/0022-1317-51-1-20","article-title":"Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene","volume":"51","author":"Leclerq","year":"2002","journal-title":"J Med Microbiol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-1759(00)00244-1","article-title":"Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA","volume":"244","author":"Velikovsky","year":"2000","journal-title":"J Immunol Methods."},{"key":"B158","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.imlet.2018.03.004","article-title":"Intraperitoneal immunization with Urease loaded N-trimethyl Chitosan nanoparticles elicits high protection against Brucella melitensis and Brucella abortus infections","volume":"199","author":"Abkar","year":"2018","journal-title":"Immunol Lett."},{"key":"B159","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","article-title":"Nanoparticle-based vaccines against respiratory viruses","volume":"10","author":"Al-Halifa","year":"2019","journal-title":"Front Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.micpath.2018.04.050","article-title":"Study of serum bactericidal and splenic activity of Total-OMP-CagA combination from Brucella abortus and Helicobacter pylori in BALB\/c mouse model","volume":"121","author":"Abadi","year":"2018","journal-title":"Microb Pathog."},{"key":"B162","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.vaccine.2015.03.033","article-title":"Development of a dual vaccine for prevention of Brucella abortus infection and Escherichia coli O157: H7 intestinal colonization","volume":"33","author":"Iannino","year":"2015","journal-title":"Vaccine."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-019-0714-3","article-title":"Rev1 wbdR tagged vaccines against Brucella ovis","volume":"50","author":"Arag\u00f3n-Aranda","year":"2019","journal-title":"Vet Res"},{"key":"B164","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/microorganisms8030436","article-title":"Application of an O-linked glycosylation system in Yersinia enterocolitica serotype O: 9 to generate a new candidate vaccine against Brucella abortus","volume":"8","author":"Huang","year":"2020","journal-title":"Microorganisms"},{"key":"B165","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11250-018-1517-7","article-title":"Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB\/c mice","volume":"50","author":"Lin","year":"2018","journal-title":"Trop Anim Health Prod."},{"key":"B166","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","article-title":"Liposomes used as a vaccine adjuvant-delivery system: from basics to clinical immunization","volume":"303","author":"Wang","year":"2019","journal-title":"J Control Rel."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","article-title":"Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544","volume":"31","author":"Goel","year":"2013","journal-title":"Vaccine."},{"key":"B168","doi-asserted-by":"publisher","first-page":"ftx124","DOI":"10.1093\/femspd\/ftx124","article-title":"Brucella abortus lysed cells using GI24 induce robust immune response and provide effective protection in Beagles","volume":"76","author":"Kim","year":"2018","journal-title":"Pathogens Dis"},{"key":"B169","first-page":"68","article-title":"Protective efficacy of an inactivated Brucella abortus vaccine candidate lysed by GI24 against brucellosis in Korean black goats","volume":"83","author":"Kim","year":"2019","journal-title":"Can J Vet Res."},{"key":"B170","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.vetimm.2015.04.008","article-title":"Immune responses and protection induced by Brucella suis S2 bacterial ghosts in mice","volume":"166","author":"Liu","year":"2015","journal-title":"Vet Immunol Immunopathol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1292\/jvms.16-0036","article-title":"Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine models","volume":"2016","author":"Kwon","year":"2016","journal-title":"J Vet Medical Sci."},{"key":"B172","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.925773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T01:41:35Z","timestamp":1658108495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.925773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,18]]},"references-count":172,"alternative-id":["10.3389\/fvets.2022.925773"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.925773","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,18]]},"article-number":"925773"}}